NCT04561492View on ClinicalTrials.gov

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

December 21, 2029

Study Completion Date

May 21, 2030

Conditions
Multiple Myeloma
Interventions
DRUG

[68Ga]Ga-PentixaFor

Tomography by emission of positons (PET) with theradiopharmaceutic \[68Ga\]Ga-PentixaFor

Trial Locations (5)

Unknown

NOT_YET_RECRUITING

CHU Bordeaux, Bordeaux

NOT_YET_RECRUITING

CHU Lille, Lille

NOT_YET_RECRUITING

HCL, Lyon

RECRUITING

Nantes UH, Nantes

NOT_YET_RECRUITING

APHP - Site Tenon, Paris

All Listed Sponsors
lead

Nantes University Hospital

OTHER